Cadeddu John J.

CIK 00015279317 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001527931

Recent Transactions

50 trades

Conversion
WEALTHFRONT CORP$WLTH
Common Stock
2025-12-15+1,134,899→ 1,167,469 total
Conversion
WEALTHFRONT CORP$WLTH
Common Stock
2025-12-15+10,738,874→ 11,047,106 total
Conversion
WEALTHFRONT CORP$WLTH
Common Stock
2025-12-15+1,598,899→ 1,598,899 total
Conversion
WEALTHFRONT CORP$WLTH
Series C Preferred Stock
2025-12-15−430,596→ 0 total
Conversion
WEALTHFRONT CORP$WLTH
Series C Preferred Stock
2025-12-15−4,074,426→ 0 total
Conversion
WEALTHFRONT CORP$WLTH
Series C Preferred Stock
2025-12-15−787,400→ 0 total
Conversion
WEALTHFRONT CORP$WLTH
Series D Preferred Stock
2025-12-15−462,842→ 0 total
Conversion
WEALTHFRONT CORP$WLTH
Series D Preferred Stock
2025-12-15−4,379,624→ 0 total
Conversion
WEALTHFRONT CORP$WLTH
Series D Preferred Stock
2025-12-15−333,176→ 0 total
Conversion
WEALTHFRONT CORP$WLTH
Series E Preferred Stock
2025-12-15−133,936→ 0 total
Conversion
WEALTHFRONT CORP$WLTH
Series E Preferred Stock
2025-12-15−1,267,374→ 0 total
Conversion
WEALTHFRONT CORP$WLTH
Series F Preferred Stock
2025-12-15−46,568→ 0 total
Conversion
WEALTHFRONT CORP$WLTH
Series F Preferred Stock
2025-12-15−440,642→ 0 total
Conversion
WEALTHFRONT CORP$WLTH
Series G Preferred Stock
2025-12-15−48,124→ 0 total
Conversion
WEALTHFRONT CORP$WLTH
Series G Preferred Stock
2025-12-15−455,376→ 0 total
Conversion
WEALTHFRONT CORP$WLTH
Series G Preferred Stock
2025-12-15−377,624→ 0 total
Conversion
WEALTHFRONT CORP$WLTH
Series G-1 Preferred Stock
2025-12-15−12,833→ 0 total
Conversion
WEALTHFRONT CORP$WLTH
Series G-1 Preferred Stock
2025-12-15−121,432→ 0 total
Conversion
WEALTHFRONT CORP$WLTH
Series G-1 Preferred Stock
2025-12-15−100,699→ 0 total
Other
Corner Growth Acquisition Corp.
Class A ordinary shares
2022-01-20−0→ 9,825,000 total
Other
CORNER GROWTH ACQUISITION CORP. 2
Class A ordinary shares
2022-01-20−0→ 4,475,000 total
Other
Corner Growth Acquisition Corp.
Class B ordinary shares
2020-12-24−62,500→ 9,825,001 total
Conversion
ARMO BioSciences, Inc.
Common Stock
2018-01-30+1,059,148→ 1,059,148 total
Conversion
ARMO BioSciences, Inc.
Common Stock
2018-01-30+2,580→ 2,580 total
Conversion
ARMO BioSciences, Inc.
Common Stock
2018-01-30+728,080→ 1,787,228 total
Conversion
ARMO BioSciences, Inc.
Common Stock
2018-01-30+1,772→ 4,352 total
Conversion
ARMO BioSciences, Inc.
Common Stock
2018-01-30+489→ 4,841 total
Conversion
ARMO BioSciences, Inc.
Common Stock
2018-01-30+551→ 5,392 total
Conversion
ARMO BioSciences, Inc.
Common Stock
2018-01-30+446→ 5,838 total
Conversion
ARMO BioSciences, Inc.
Series A Preferred Stock
2018-01-30−2,580→ 0 total
Conversion
ARMO BioSciences, Inc.
Series B-1 Preferred Stock
2018-01-30−200,786→ 0 total
Conversion
ARMO BioSciences, Inc.
Series C Preferred Stock
2018-01-30−226,543→ 0 total
Conversion
ARMO BioSciences, Inc.
Series C Preferred Stock
2018-01-30−551→ 0 total
Conversion
ARMO BioSciences, Inc.
Series C-1 Preferred Stock
2018-01-30−446→ 0 total
Conversion
ARMO BioSciences, Inc.
Series B Preferred Stock
2018-01-30−728,080→ 0 total
Conversion
ARMO BioSciences, Inc.
Series A Preferred Stock
2018-01-30−1,059,148→ 0 total
Conversion
ARMO BioSciences, Inc.
Common Stock
2018-01-30+200,786→ 1,988,014 total
Conversion
ARMO BioSciences, Inc.
Common Stock
2018-01-30+226,543→ 2,214,557 total
Conversion
ARMO BioSciences, Inc.
Common Stock
2018-01-30+183,351→ 2,397,908 total
Conversion
ARMO BioSciences, Inc.
Series B Preferred Stock
2018-01-30−1,772→ 0 total
Conversion
ARMO BioSciences, Inc.
Series B-1 Preferred Stock
2018-01-30−489→ 0 total
Conversion
ARMO BioSciences, Inc.
Series C-1 Preferred Stock
2018-01-30−183,351→ 0 total
Conversion
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2014-10-21+1,902,798→ 1,902,798 total
Conversion
Atara Biotherapeutics, Inc.$ATRA
Series A Preferred
2014-10-21−1,278,935→ 0 total
Conversion
Atara Biotherapeutics, Inc.$ATRA
Series A Preferred
2014-10-21−3,115→ 0 total
Conversion
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2014-10-21+4,634→ 4,634 total
Conversion
Atara Biotherapeutics, Inc.$ATRA
Series B Preferred
2014-10-21−1,519→ 0 total
Conversion
Atara Biotherapeutics, Inc.$ATRA
Series B Preferred
2014-10-21−623,863→ 0 total
Sale
YuMe Inc
Common Stock
2014-03-07$6.51/sh−3,830→ 272,639 total
Sale
YuMe Inc
Common Stock
2014-03-07$6.51/sh−41→ 2,932 total

Companies

Recent Filings

Address

251 LYTTON AVENUE, SUITE 200

PALO ALTO, CA, 94301

View on SEC.gov